Expansion potential BIOLASE is investing to expand manufacturing capacity and upgrade cleanrooms, fiber and laser rooms in Corona, California, signaling a need for scalable supply chain partnerships, materials, and equipment that can support higher production volumes and long-term stability.

Channel growth MegaGen-led and MegaGen America-supported initiatives indicate a push to broaden global and U.S. sales and distribution, presenting opportunities to align service, training, and localized support offerings with a growing network of dealers and clinicians.

Clinical leadership BIOLASE consistently showcases advanced YSGG laser protocols for periodontal, implant, and resective treatments at major meetings, presenting opportunities to partner on clinical education programs, case studies, and adoption-driven promotions to drive demand.

Ownership shift The acquisition by MegaGen Implant in 2025 marks a strategic realignment that may open cross-sell opportunities with implantology portfolios, as well as potential collaborations on integrative dental workflows and bundled solutions.

Financial resilience Despite past Chapter 11 proceedings and Nasdaq delisting events, BIOLASE reports substantial revenue scale and recurring consumable subscriptions, suggesting opportunities to offer aftermarket services, consumables, and financing options to stabilize and grow customer lifetime value.